Purpose. To compare the use of topical tranexamic acid (TXA) with postoperative autologous transfusion (PAT) in terms of blood loss, need for allogeneic blood transfusion, and cost-effectiveness. Methods. Records of 25 men and 125 women (mean age, 67 years) who underwent primary unilateral total knee arthroplasty (TKA) and were randomised to the PAT group (n=50), topical TXA group (n=50), or routine drainage group (control) [n=50] were reviewed. Pre-and post-operative haemoglobin level, total postoperative drainage volume, and the need for allogeneic blood transfusion were recorded. Results. The 3 groups were comparable in terms of age, gender, and preoperative haemoglobin level. The total postoperative drainage volume was lower in the TXA group than the PAT or routine drainage groups (174.48 vs. 735 vs. 760 ml, p<0.001). The postoperative haemoglobin level was lower in the routine drainage group than the PAT or TXA groups on day 1 (11.67 vs.
introduction
To reduce blood loss and the need for allogeneic blood transfusion during total knee arthroplasty (TKA), application of controlled hypotensive anaesthesia, delayed drainage, tourniquet release before wound closure, topical or systemic tranexamic acid (TXA), and postoperative autologous transfusion (PAT) has been advocated. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] TXA is an analogue of the amino acid lysine. When administered systemically, TXA competitively inhibits plasminogen activation and plasmin binding to fibrin, thus inhibiting fibrin degradation. When used topically, TXA acts directly on microvasculature and clot stabilisation, thus reducing local bleeding. [4] [5] [6] [7] 14, 15 PAT re-infuses blood collected in the surgical drain into the patient and thus reduces the need for allogeneic blood transfusion. [8] [9] [10] [11] [12] [13] This study compared the use of topical TXA with PAT in terms of blood loss, need for allogeneic blood transfusion, and cost-effectiveness.
Materials and Methods
This study was approved by the ethics committee of our hospital. Records of 176 patients who underwent primary unilateral TKA between October 2013 and November 2014 by a single team of surgeons with standardised anaesthetic and surgical protocols were reviewed. Of them, 26 patients with a history of venous thromboembolism, preoperative use of anticoagulants (acetylsalicylic acid, enoxaparin, or any other oral or intravenous agent), obvious anaemia or coagulopathy before surgery were excluded. The remaining 25 men and 125 women (mean age, 67 years) were randomised to the PAT group (n=50), topical TXA group (n=50), or routine drainage group (control) [n=50].
Cemented TKA was performed through a standard medial parapatellar approach with tourniquet use under spinal or regional block or general anaesthesia. A posterior cruciate ligamentpreserving prosthesis was used. The patellar surface was not changed. An intramedullary guide was used for femoral preparation, and an extramedullary guide was used for tibial preparation. Thromboembolismdeterrent stockings and enoxaparin (40 mg before surgery and continued daily for 10 days) were used as venous thromboembolism prophylaxis. 16 For the topical TXA group, a drain and injector tip were placed within the joint before closing the arthrotomy. The drain was clamped and 1.5 g TXA (Transamine, FAKO, Istanbul, Turkey) diluted in 100 ml normal saline was injected intra-articularly via the injector tip. The drain was released after one hour.
For the PAT group, the CellTrans (SUMMIT, Gloucestershire, UK) was used. A drain was inserted into the knee joint at the end of TKA, and low suction drainage was started 30 minutes later. More than 150 ml of blood had accumulated within 6 hours and was re-infused into the patient. After that, the system was used as a normal closed drain system.
For the controls, a low-suction drain was placed in the knee joint and removed after 24 hours.
Blood transfusion was indicated when the haemoglobin (Hb) level fell below 8 g/dl or the patient was symptomatic of anaemia. The postoperative Hb level was measured daily, and the lowest value was used for analysis. Transfusion cost per 1 unit of red blood cells was estimated to be $60 in 2014 at our hospital; the cost of 1.5 g of TXA was approximately $4 and the cost of PAT using the CellTrans system was approximately $243 in 2014. [17] [18] [19] [20] Doppler ultrasonography was used to detect proximal or distal deep venous thrombosis. Ventilation/perfusion scanning or spiral computed tomography was used only when pulmonary embolism was suspected clinically; this avoided unnecessary exposure to radiation and additional costs.
The normality of distribution of the continuous variables was tested by the Kolmogorov-Smirnov test. The ANOVA test was used for normally distributed numerical variables (Hb level), whereas the Kruskal-Wallis test was used for non-normally distributed numerical variables (drain volume). Sub-group analyses were made using the Mann-Whitney U test. Patients who did or did not receive allogeneic blood transfusion were compared using the Chi-square test. A value of p<0.05 was considered statistically significant.
results
The 3 groups were comparable in terms of age, gender, and preoperative haemoglobin level (Table) . The total postoperative drainage volume was lower in the TXA group than the PAT or routine drainage groups (174.48 vs. 735 vs. 760 ml, p<0.001). The postoperative Hb level was lower in the routine drainage group than the PAT or TXA groups on day 1 (11.67 vs. 12.33 vs. 12.40 g/dl, p<0.001) and day 3 (9.9 vs. 10.7 vs. 11.14 g/dl, p<0.001). The number of patients who received allogeneic blood transfusion was higher in the routine drainage group (12 and 4 patients received 1 and 2 units of blood, respectively) 
discussion
It is important to reduce blood loss during TKA in elderly patients with limited cardiovascular function. Tourniquet use is the most common method to limit blood loss. 21 Application of PAT and topical or systemic TXA to achieve surgical haemostasis without tourniquet use is increasingly popular.
Compared with routine drainage, PAT enabled a higher postoperative Hb level and lower blood loss, with the cost of PAT being $75 and the cost of allogeneic blood transfusion (including crossmatching, delivery and refrigerated storage) being $761. 8 Another study reported the cost for one unit of allogeneic blood transfusion as $787 and the cost of TXA as $58. 6 In a meta-analysis, the use of PAT reduced the need for allogeneic blood transfusion and decreased postoperative hospital costs. 22 In our study, TXA was cheaper, more accessible, and easier to apply than PAT, although there was no significant difference in postoperative Hb level between TXA and PAT. Topical application of TXA is more or equally effective compared with systemic use. 5, 23, 24 The amount of systemic absorption of TXA following topical application can be clinically disregarded. 14 There is no evidence that topical or systemic application of TXA is associated with an increased rate of venous thromboembolism, myocardial infraction, or stroke. [4] [5] [6] [7] [8] [25] [26] [27] The dosage of topical TXA varies and has been reported to be 3 g TXA/100 ml saline, 5 1 g TXA/10 ml saline, 6 1.5 g TXA/50 ml saline, 28 and 1.5 g and 3 g TXA/100 ml saline. 14 This study had several limitations. It was retrospective. Postoperative pain, wound healing, and time to discharge were not evaluated. TKAs were performed by 2 different surgeons, but the anaesthetic and surgical protocols and prosthesis were standardised.
conclusion Compared with PAT, topical TXA was more costeffective and resulted in less total postoperative drainage volume and less need for allogeneic blood transfusion.
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